Endoscopic Management of Pre-invasive Esophageal Adenocarcinoma

Chapter

Abstract

A 50-year old white male presents for surveillance endoscopy for Barrett’s esophagus. He was diagnosed with Barrett’s esophagus 3 years ago after he underwent upper endoscopy for longstanding heartburn. Biopsies from the esophagus then showed intestinal metaplasia with no dysplasia. Currently, upper endoscopy reveals columnar mucosa in the distal 6 cm of the esophagus with no discernible mucosal nodularity. Biopsies show high grade dysplasia. He has no other complaints or comorbidities and physical examination is unremarkable.

Keywords

Migration Catheter Dioxide Ischemia Argon 

References

  1. 1.
    Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797PubMedCrossRefGoogle Scholar
  2. 2.
    Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, Cameron A, Corley D, Falk G, Goldblum J, Hunter J, Jankowski J, Lundell L, Reid B, Shaheen NJ, Sonnenberg A, Wang K, Weinstein W (2004) A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology 127:310–330PubMedCrossRefGoogle Scholar
  3. 3.
    Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146PubMedCrossRefGoogle Scholar
  4. 4.
    Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627–1633PubMedGoogle Scholar
  5. 5.
    Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 119:333–338PubMedCrossRefGoogle Scholar
  6. 6.
    Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE (2006) Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol 4:566–572PubMedCrossRefGoogle Scholar
  7. 7.
    Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P (2009) Esophageal adenocarcinoma in Barrett’s esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 104:502–513PubMedCrossRefGoogle Scholar
  8. 8.
    Tschanz ER (2005) Do 40% of patients resected for barrett esophagus with high-grade dysplasia have unsuspected adenocarcinoma? Arch Pathol Lab Med 129:177–180PubMedGoogle Scholar
  9. 9.
    Wang VS, Hornick JL, Sepulveda JA, Mauer R, Poneros JM (2009) Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett’s esophagus: a 20-year experience. Gastrointest Endosc 69:777–783PubMedCrossRefGoogle Scholar
  10. 10.
    Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD (2008) Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85:424–429PubMedCrossRefGoogle Scholar
  11. 11.
    Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137PubMedCrossRefGoogle Scholar
  12. 12.
    Peyre CG, DeMeester SR, Rizzetto C, Bansal N, Tang AL, Ayazi S, Leers JM, Lipham JC, Hagen JA, DeMeester TR (2007) Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann Surg 246:665–671, discussion 671–674PubMedCrossRefGoogle Scholar
  13. 13.
    Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS (1993) Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium. Gastroenterology 104:1686–1691PubMedGoogle Scholar
  14. 14.
    Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS (1993) Regression of Barrett’s esophagus by laser ablation in an anacid environment. Dig Dis Sci 38:365–368PubMedCrossRefGoogle Scholar
  15. 15.
    Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ (2004) Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60: 703–710PubMedCrossRefGoogle Scholar
  16. 16.
    Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, Portale G, Cavallin F, Rugge M (2008) Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 15:3278–3288PubMedCrossRefGoogle Scholar
  17. 17.
    Migliore M, Choong CK, Lim E, Goldsmith KA, Ritchie A, Wells FC (2007) A surgeon’s case volume of oesophagectomy for cancer strongly influences the operative mortality rate. Eur J Cardiothorac Surg 32:375–380PubMedCrossRefGoogle Scholar
  18. 18.
    Tada M, Murata M, Tamekoto T (1984) The development of “strip-off” biopsy. Gastroenterol Endosc 26:883–889Google Scholar
  19. 19.
    Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M (1993) Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 39:58–62PubMedCrossRefGoogle Scholar
  20. 20.
    Tanabe S, Koizumi W, Kokutou M, Imaizumi H, Ishii K, Kida M, Yokoyama Y, Ohida M, Saigenji K, Shimao H, Mitomi H (1999) Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer. Gastrointest Endosc 50:819–822PubMedCrossRefGoogle Scholar
  21. 21.
    Seewald S, Akaraviputh T, Seitz U, Brand B, Groth S, Mendoza G, He X, Thonke F, Stolte M, Schroeder S, Soehendra N (2003) Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57:854–859PubMedCrossRefGoogle Scholar
  22. 22.
    Mino-Kenudson M, Hull MJ, Brown I, Muzikansky A, Srivastava A, Glickman J, Park DY, Zuckerberg L, Misdraji J, Odze RD, Lauwers GY (2007) EMR for Barrett’s esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 66:660–666, quiz 767, 769PubMedCrossRefGoogle Scholar
  23. 23.
    Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H (2005) EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc 62:16–23PubMedCrossRefGoogle Scholar
  24. 24.
    Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118:670–677PubMedCrossRefGoogle Scholar
  25. 25.
    Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206PubMedCrossRefGoogle Scholar
  26. 26.
    Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology 137(3):815–823PubMedCrossRefGoogle Scholar
  27. 27.
    Ishihara R, Iishi H, Takeuchi Y, Kato M, Yamamoto S, Yamamoto S, Masuda E, Tatsumi K, Higashino K, Uedo N, Tatsuta M (2008) Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67:799–804PubMedCrossRefGoogle Scholar
  28. 28.
    Esaki M, Matsumoto T, Hirakawa K, Nakamura S, Umeno J, Koga H, Yao T, Iida M (2007) Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 39:41–45PubMedCrossRefGoogle Scholar
  29. 29.
    Pouw RE, Peters FP, Sempoux C, Piessevaux H, Deprez PH (2008) Stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia: report on a Brussels’ cohort. Endoscopy 40:892–898PubMedCrossRefGoogle Scholar
  30. 30.
    Peters FP, Kara MA, Rosmolen WD, ten Kate FJ, Krishnadath KK, van Lanschot JJ, Fockens P, Bergman JJ (2006) Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101:1449–1457PubMedCrossRefGoogle Scholar
  31. 31.
    Gotoda T (2007) Endoscopic resection of early gastric cancer. Gastric Cancer 10:1–11PubMedCrossRefGoogle Scholar
  32. 32.
    Ishihara R, Iishi H, Uedo N, Takeuchi Y, Yamamoto S, Yamada T, Masuda E, Higashino K, Kato M, Narahara H, Tatsuta M (2008) Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 68:1066–1072PubMedCrossRefGoogle Scholar
  33. 33.
    Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70(5):860–866PubMedCrossRefGoogle Scholar
  34. 34.
    Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288PubMedCrossRefGoogle Scholar
  35. 35.
    Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905PubMedCrossRefGoogle Scholar
  36. 36.
    Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62:488–498PubMedCrossRefGoogle Scholar
  37. 37.
    Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV Jr, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 66:460–468PubMedCrossRefGoogle Scholar
  38. 38.
    Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132:1226–1233PubMedCrossRefGoogle Scholar
  39. 39.
    Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS (2007) Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc 65:60–66PubMedCrossRefGoogle Scholar
  40. 40.
    Yachimski P, Puricelli WP, Nishioka NS (2008) Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol 6:302–308PubMedCrossRefGoogle Scholar
  41. 41.
    Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, Grool TE, van Veen RL, Sterenborg HJ, Kuipers EJ (2004) 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial. Gut 53:785–790PubMedCrossRefGoogle Scholar
  42. 42.
    Peters F, Kara M, Rosmolen W, Aalders M, Ten Kate F, Krishnadath K, van Lanschot J, Fockens P, Bergman J (2005) Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy 37:418–424PubMedCrossRefGoogle Scholar
  43. 43.
    Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS (2008) Utility of biomarkers in prediction of response to ablative therapy in Barrett’s esophagus. Gastroenterology 135:370–379PubMedCrossRefGoogle Scholar
  44. 44.
    Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Westra WM, Lutzke LS, Borkenhagen LS, Dunagan K (2008) Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 113:470–476PubMedCrossRefGoogle Scholar
  45. 45.
    Gage AA, Baust J (1998) Mechanisms of tissue injury in cryosurgery. Cryobiology 37:171–186PubMedCrossRefGoogle Scholar
  46. 46.
    Pasricha PJ, Hill S, Wadwa KS, Gislason GT, Okolo PI 3rd, Magee CA, Canto MI, Kuo WH, Baust JG, Kalloo AN (1999) Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc 49:627–631PubMedCrossRefGoogle Scholar
  47. 47.
    Johnston CM, Schoenfeld LP, Mysore JV, Dubois A (1999) Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc 50:86–92PubMedCrossRefGoogle Scholar
  48. 48.
    Greenwald BD, Dumot JA, Horwhat JD, Lightdale CJ, Abrams JA (2010) Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus 23(1):13–19PubMedCrossRefGoogle Scholar
  49. 49.
    Dumot JA, Vargo JJ 2nd, Falk GW, Frey L, Lopez R, Rice TW (2009) An open-label, prospective trial of cryospray ablation for Barrett’s esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 70(4):634–644CrossRefGoogle Scholar
  50. 50.
    Sampliner RE, Faigel D, Fennerty MB, Lieberman D, Ippoliti A, Lewin K, Weinstein WM (2001) Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53:554–558PubMedCrossRefGoogle Scholar
  51. 51.
    Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, Prasad A, Sampliner RE (2006) A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 55:1233–1239PubMedCrossRefGoogle Scholar
  52. 52.
    Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A (2005) Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus. Gastrointest Endosc 61:232–240PubMedCrossRefGoogle Scholar
  53. 53.
    Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, Blaya C (2000) High power setting argon plasma coagulation for the eradication of Barrett’s esophagus. Am J Gastroenterol 95:1661–1668PubMedCrossRefGoogle Scholar
  54. 54.
    Mork H, Al-Taie O, Berlin F, Kraus MR, Scheurlen M (2007) High recurrence rate of Barrett’s epithelium during long-term follow-up after argon plasma coagulation. Scand J Gastroenterol 42:23–27PubMedCrossRefGoogle Scholar
  55. 55.
    Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Deviere J (2002) Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34:950–955PubMedCrossRefGoogle Scholar
  56. 56.
    Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G (2003) Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus. Clin Gastroenterol Hepatol 1:258–263PubMedCrossRefGoogle Scholar
  57. 57.
    Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR (2000) The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol 95:3383–3387PubMedCrossRefGoogle Scholar
  58. 58.
    Yachimski P, Puricelli WP, Nishioka NS (2009) Patient predictors of histopathologic response after photodynamic therapy of Barrett’s esophagus with high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 69:205–212PubMedCrossRefGoogle Scholar
  59. 59.
    Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 120:1630–1639PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyMayo ClinicRochesterUSA
  2. 2.Division of Gastroenterology and HepatologyMayo ClinicRochesterUSA

Personalised recommendations